BridgeMD
New treatment option for Colorectal Cancer
Official title Pre-emptive Endoscopic Vacuum Therapy Reduces the Incidence of Anastomotic Leakage After Colorectal Cancer Surgery
ClinicalTrials.gov ID: NCT07208786
What this study is testing
- What it's testing
- Evaluate the safety and efficacy of postoperative Pre-emptive EVT (PEVT) in reducing the incidence of anastomotic leaks within 30 days after surgery in patients with colorectal cancer. Compare the differences between the PEVT group and the control group in terms of operation time, length of hospital stay, and total medical costs.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- Pathologically diagnosed with colorectal cancer, planned for radical surgery (right hemicolectomy, left hemicolectomy, or anterior resection of the...
- Age 18-85 years, American Society of Anesthesiologists (ASA) classification I-III.
- Anastomosis to be performed in a single stage (meeting anastomotic criteria).
- Patient or legal guardian is able to understand and sign the informed consent form and comply with follow-up.
You likely can't join if
- Preexisting anastomotic leakage or severe intra-abdominal infection before surgery.
- Complicated by severe cardiovascular or cerebrovascular diseases (e.g., acute myocardial infarction, acute phase of cerebral infarction).
- Severe liver or kidney dysfunction (liver function Child-Pugh class C, creatinine clearance \<30 ml/min).
- Coagulation disorders (platelets \ 1.5) or receiving anticoagulant therapy that cannot be adjusted.
- History of abdominal radiotherapy or multiple abdominal surgeries leading to severe intra-abdominal adhesions.
- Complicated by other malignant tumors and currently undergoing radiotherapy or chemotherapy.
See the full eligibility criteria
- Pathologically diagnosed with colorectal cancer, planned for radical surgery (right hemicolectomy, left hemicolectomy, or anterior resection of the rectum, etc.).
- Age 18-85 years, American Society of Anesthesiologists (ASA) classification I-III.
- Anastomosis to be performed in a single stage (meeting anastomotic criteria).
- Patient or legal guardian is able to understand and sign the informed consent form and comply with follow-up.
- Preexisting anastomotic leakage or severe intra-abdominal infection before surgery.
- Complicated by severe cardiovascular or cerebrovascular diseases (e.g., acute myocardial infarction, acute phase of cerebral infarction).
- Severe liver or kidney dysfunction (liver function Child-Pugh class C, creatinine clearance \<30 ml/min).
- Coagulation disorders (platelets \ 1.5) or receiving anticoagulant therapy that cannot be adjusted.
- History of abdominal radiotherapy or multiple abdominal surgeries leading to severe intra-abdominal adhesions.
- Complicated by other malignant tumors and currently undergoing radiotherapy or chemotherapy.
- Psychiatric illness or cognitive impairment preventing compliance with the study.
The study team makes the final eligibility decision.
Where it's taking place
- Nanchong, Sichuan, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nanchong, Sichuan, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.